Prefilled drug delivery device specialist Apiject has signed a lease for a new site in Apex, North Carolina, that will house two blow-fill-seal production lines.
The 30,000-square-foot facility will operate as a FDA-registered 503B outsourcing plant that will churn out generic injectable drugs on the agency’s shortage list, the company said in a Jan. 16 press release.
Financial terms related to the lease and the overall cost and completion date of the project were not disclosed…